CNP
70
2
PNR
30
-2
BLK
49
3
PEP
56
3
COST
53
2
FE
62
2
AAP
26
-7
GE
55
-5
PH
60
-2
DRI
45
5
PFE
45
-15
OKE
48
2
BMY
66
-3
EXR
44
4
AIZ
61
5
PNC
59
3
MUR
49
2
MCK
64
2
NWL
39
-2
A
37
3
CNP
70
2
PNR
30
-2
BLK
49
3
PEP
56
3
COST
53
2
FE
62
2
AAP
26
-7
GE
55
-5
PH
60
-2
DRI
45
5
PFE
45
-15
OKE
48
2
BMY
66
-3
EXR
44
4
AIZ
61
5
PNC
59
3
MUR
49
2
MCK
64
2
NWL
39
-2
A
37
3
Financhill
Back

U.S. Global Investors, Inc. Vs. Celldex Therapeutics, Inc. Industry Stock Comparison

Sell
48

GROW
U.S. Global Investors, Inc.

Last Price:
$2.66
Seasonality Move:
5.81%
Sell
48

CLDX
Celldex Therapeutics, Inc.

Last Price:
$31.05
Seasonality Move:
20.93%
Sell
48
U.S. Global Investors, Inc. (GROW) is a Sell

Is U.S. Global Investors, Inc. a Buy, Sell or Hold?

  • The current U.S. Global Investors, Inc. [GROW] share price is $2.67. The Score for GROW is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • GROW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Celldex Therapeutics, Inc. (CLDX) is a Sell

Is Celldex Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Celldex Therapeutics, Inc. [CLDX] share price is $31.05. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GROW Stock Price Chart

What is U.S. Global Investors, Inc.'s stock price today?

  • The U.S. Global Investors, Inc. share price today is $2.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GROW is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLDX Stock Price Chart

What is Celldex Therapeutics, Inc.'s stock price today?

  • The Celldex Therapeutics, Inc. share price today is $31.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

GROW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 36.18 Sell
Chaikin Money Flow: 58087 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.76 - 3.34) Sell
Bollinger Bands (100): (2.38 - 3.16) Sell

CLDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.9 Buy
Relative Strength Index (14 RSI): 55.97 Buy
Chaikin Money Flow: 3988094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.43 - 31.31) Buy
Bollinger Bands (100): (24.48 - 29.54) Buy

GROW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.67 Sell
20-day SMA: 2.98 Sell
50-day SMA: 3.11 Sell
200-day SMA: 2.64 Buy
8-day EMA: 2.63 Buy
20-day EMA: 2.23 Buy
50-day EMA: 1.35 Buy
200-day EMA: 0.43 Buy

CLDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.05 Buy
20-day SMA: 30.57 Buy
50-day SMA: 27.66 Buy
200-day SMA: 25.4 Buy
8-day EMA: 30.94 Buy
20-day EMA: 30.26 Buy
50-day EMA: 28.67 Buy
200-day EMA: 26.26 Buy

U.S. Global Investors, Inc. Earnings Growth & GROW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Celldex Therapeutics, Inc. Earnings Growth & CLDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.19 per share, and an increase next year of $0.04 per share.

U.S. Global Investors, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Celldex Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):